Evidence map›Paper›PMID 34204383›Full record

ArticleInternational journal of environmental research and public health2021

Prevalence of SARS-CoV-2 Infection at the University of Barcelona during the Third COVID-19 Pandemic Wave in Spain.

Sebastián Videla, Aurema Otero, Sara Martí, M Ángeles Domínguez, Nuria Fabrellas, M Pilar Delgado-Hito, Imma Cruz, Cristian Tebé, Teresa Vinuesa, Fernando Ardila and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sebastián VidelaPharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0001-5049-1379
Aurema OteroClinical Research Support Unit (HUB-IDIBELL), Clinical Pharmacology Department, Bellvitge University Hospital, L'Hospitalet del Llobregat, 08907 Barcelona, Spain.ORCID 0000-0001-9708-9408
Sara MartíMicrobiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
M Ángeles DomínguezMicrobiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Nuria FabrellasDepartment of Public Health Nursing, Mental Health and Maternal and Childhood, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.
M Pilar Delgado-HitoDepartment of Fundamental and Medical-Surgical Nursing, School of Medicine and Health Sciences, GRIN-IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Imma CruzOSSMA (Oficina de Seguretat, Salut i Medi Ambient), University of Barcelona, 08028 Barcelona, Spain.
Cristian TebéBiostatistical Unit, Department of Clinical Sciences, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Teresa VinuesaMicrobiology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0002-3536-4109
Fernando ArdilaUICEC-IDIBELL (Clinical Research Organization), L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Marta SanchoGerència Territorial Metropolitana Sud, Catalan Institute of Health, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Esteve FernándezConsortium for Biomedical Research in Respiratory Diseases (CIBERES), 28029 Madrid, Spain.ORCID 0000-0003-4239-723X
Montserrat FiguerolaGerència Territorial Metropolitana Sud, Catalan Institute of Health, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
Francisco CiruelaPharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.ORCID 0000-0003-0832-3739
Institut d'Investigació Biomédica de Bellvitge · ESBellvitge University Hospital · ESUniversitat de Barcelona · ES

Funding

Official Chamber of Commerce, Industry and Navigation of Barcelona COVID-19 special funding
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic started in December 2019 and still is a major global health challenge. Lockdown measures and social distancing sparked a global shift towards online learning, which deeply impacted universities' daily life, and the University of Barcelona (UB) was not an exception. Accordingly, we aimed to determine the impact of the SARS-CoV-2 pandemic at the UB. To that end, we performed a cross-sectional study on a sample of 2784 UB members (

Indexed as

COVID-19PandemicsCommunicable Disease ControlCross-Sectional StudiesHumansPrevalenceSARS-CoV-2Spainadministrative and service staffcoronavirusCOVID-19 prevalencefaculty membersinfection statusSARS-CoV-2seroprevalenceSpainstudentsuniversity community

Identifiers

PMID34204383
PMCPMC8296357
OpenAlexW3170953482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.